Introduction
B-Cell Chronic Lymphocytic Leukemia - Overview
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Assessment
B-Cell Chronic Lymphocytic Leukemia - Companies Involved in Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Drug Profiles
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products
B-Cell Chronic Lymphocytic Leukemia - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AB Science SA, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Aduro BioTech Inc, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AstraZeneca Plc, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BeiGene Ltd, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioIntegrator Ltd, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H1 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H1 2020 (Contd..1), H1 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H1 2020 (Contd..2), H1 2020
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• AB Science SA
• Aduro BioTech Inc
• AstraZeneca Plc
• BeiGene Ltd
• BioIntegrator Ltd
• BioInvent International AB
• BioXpress Therapeutics SA
• Bristol-Myers Squibb Co
• CRISPR Therapeutics AG
• Elsalys Biotech SA
• Generon (Shanghai) Corp Ltd
• iDD biotech SAS
• Juno Therapeutics Inc
• Loxo Oncology Inc
• Merck & Co Inc
• Millennium Pharmaceuticals Inc
• Molecular Templates Inc
• Nordic Nanovector ASA
• Novartis AG
• Noxxon Pharma AG
• Oncology Venture U.S. Inc
• Ono Pharmaceutical Co Ltd
• Portola Pharmaceuticals Inc
• Regeneron Pharmaceuticals Inc
• Samumed LLC
• Shanghai Pharmaceutical Group Co Ltd
• Sunesis Pharmaceuticals Inc
• TheraMAB LLC
• Xencor Inc
• Zhejiang DTRM Biopharma LLC